Clinical Trials Search Results

  • Resize font
  • Print
  • Email
  • Facebook
  • Twitter
  • Google+
  • Pinterest
Drug:  Ad-ISF35
Find trials that include:  Any drugs shown
Results 1-1 of 1 for your search:
Start Over
ISF35 and Pembrolizumab in Treating Patients with Refractory Metastatic Stage IIIB-IV Melanoma
Status: Not yet active
Phase: Phase II, Phase I
Type: Treatment
Age: 18 and over
Trial IDs: 2015-0199, NCI-2016-00672, NCT02719015
Start Over